About Stem Cell Therapy for Liver Cirrhosis

Tentang Terapi Sel Punca untuk Sirosis Hati

"Is liver cirrhosis incurable?" – This question frequently elicits significant anxiety and despair among many patients and their families.

Abdominal distension due to fluid accumulation (ascites), yellowing of the skin and eyes (jaundice), and lightheadedness caused by hepatic encephalopathy... These characteristic symptoms of liver cirrhosis significantly disrupt daily life and cause considerable suffering for patients. In modern medicine, it is challenging to fully cure advanced liver cirrhosis, and liver transplantation has often been cited as "the only radical treatment." However, a recent new approach in regenerative therapy, known as Stem Cell Therapy, has brought a ray of hope for liver cirrhosis.

What is Liver Cirrhosis? What are the Current Treatment Limitations?

Liver cirrhosis is a disease in which the liver becomes fibrotic and hardens, leading to serious complications. However, current treatments make fundamental recovery difficult to achieve, and hope for new regenerative therapies is growing.

Hepatic cirrhosis refers to a condition where the soft, functional liver tissue is replaced by hard, fibrous scar tissue due to chronic liver damage, resulting in the atrophy of the entire organ and a profound loss of its function.

Envision a fatty liver hardening to a concrete-like consistency after years of chronic inflammation.

Causes of Liver Cirrhosis and its Widespread Impact

There are an estimated 400,000 patients with liver cirrhosis in Indonesia, and its primary causes are as follows.

  • Hepatitis Virus (B dan C): Hepatitis jangka panjang secara bertahap merusak hati.
  • Alcoholic Liver DamageYears of alcohol consumption damages liver cells.
  • Non-Alcoholic Fatty Liver Disease (NAFLD):The causes of liver cirrhosis, a type of lifestyle disease that has been increasing rapidly recently.

Regardless of the cause, chronic inflammation continues to damage normal liver cells, fibrosis develops, and eventually liver cirrhosis occurs.

If it progresses to life-threatening complications

As hepatic cirrhosis progresses, it can lead to the following serious complications.

  • Asites: Air menumpuk di perut, menyebabkan kesulitan bernapas dan rasa tertekan.
  • Ikterus: Kulit dan mata menguning, menyebabkan kelelahan umum dan gatal-gatal.
  • Ensefalopati Hepatik:Impaired consciousness or coma due to decreased detoxification function.

Due to these complications, patients' daily lives are severely restricted, and they are continually burdened by the anxiety surrounding the timing of future hospitalizations and the potential for recurrent loss of consciousness.

The Current Reality of Medical Treatment: Focused on Symptomatic Therapy

At present, there is no treatment capable of reversing liver cirrhosis to its normal condition. Treatment is based on two approaches.

  • Pengobatan Penyebab:Elimination of virus or abstinence from alcohol.
  • Penanganan Komplikasi:Drug therapy with diuretics and ammonia-removing drugs.

However, a liver that has undergone fibrosis and hardened cannot be regenerated. The only definitive treatment is liver transplantation, but

  • Chronic donor shortage
  • Major surgical risks
  • Burden of lifelong immunosuppressive therapy

The barriers are indeed exceedingly high.

A New Strategy for 'Liver Regeneration' is Required

Therefore, liver cirrhosis is a disease whose progression can be halted by modern medical treatments, but it cannot be reversed. Consequently, regenerative therapies, such as Stem Cell Therapy, are currently attracting significant attention.

Restoring pliability and function to a fibrotic liver—such a hope will become a reality.

Key Points

  • Hepatic cirrhosis is a condition characterized by the loss of hepatic elasticity and function due to fibrosis.
  • Causing serious complications such as ascites, jaundice, and hepatic encephalopathy.
  • Current treatment focuses on etiological strategies and complication management; hepatic regeneration is challenging.
  • In the absence of a radical treatment other than liver transplantation, hope for regenerative therapy is growing.

Is Regenerative Therapy Effective for Liver Cirrhosis? Why is Stem Cell Therapy Gaining Attention?

As a new treatment for liver cirrhosis, regenerative therapy using mesenchymal stem cells (MSCs) is attracting global attention. Particularly, umbilical cord-derived MSCs are hoped to be "hope cells" that possess gentleness and potent regenerative power.

What has attracted attention in recent years for "treating" liver cirrhosis isTerapi Sel Punca.

Stem cells are undifferentiated cells within the human body that possess the capacity to differentiate into various cell types and simultaneously repair damaged tissues. In essence, they are the body's master cells.

What is Stem Cell Therapy?

Stem cell therapy is a medical treatment method that involves harvesting stem cells from the patient themselves (autologous) or a donor (allogeneic), reintroducing them into the body, and promoting the regeneration of damaged organs. In the context of hepatic cirrhosis, the objective is to deliver stem cells to damaged and fibrotic liver tissue, with the aim of restoring hepatic function and repairing the tissue.

Multiple approaches to regenerative therapy are available.

Various approaches to liver regeneration are under investigation.

  • Research on the generation and transplantation of miniature liver organoids derived from iPS cells.
  • Treatment using autologous stem cells derived from bone marrow or peripheral blood.

Among these, the method that is attracting attention as a more practical treatment is the use ofmesenchymal stem cell (MSC).

What are Mesenchymal Stem Cells (MSCs)?

Mesenchymal Stem Cells (MSCs) are stem cells primarily found in bone marrow, adipose tissue, and the umbilical cord at birth. They exhibit the following characteristics.

  • Kemampuan proliferasi dan diferensiasi tinggi:Can change into various tissues as needed.
  • Immune rejection rarely occurs.Allogeneic MSC can be safely administered with high probability.
  • Powerful anti-inflammatory and restorative action.Supporting damaged tissue and promoting regeneration.

Due to these properties, MSCs are considered an ideal cell source for liver repair.

Umbilical cord-derived MSCs are a bright star.

Di antara MSC, khususnya MSC derived from Wharton's Jelly extracted from the umbilical cord (WJ-MSC)is a cell that is superior in terms of softness and strength.

  • Sel Punca Berusia 0 Tahun:Because it's newly born, its self-replication and differentiation ability is very high.
  • Risiko Tumorigenesis Rendah:Genetically close to the initial state, high safety.
  • Rarely Causes Immune Rejection:Low HLA (human leukocyte antigen) expression, easily adaptable even with allogeneic transplantation.

Additionally, the collection imposes no burden on the infant or mother and raises no significant ethical concerns, which is a major advantage in medical applications.

Our clinic also utilizes umbilical cord-derived WJ-MSC, anticipating the definite regenerative effects inherent in these young and healthy cells for hepatic cirrhosis.

Key Points

  • Stem Cell Therapy is the most advanced regenerative therapy aimed at repairing damaged liver.
  • Mesenchymal Stem Cells (MSCs) possess high immunocompatibility and superior safety.
  • Umbilical cord-derived WJ-MSCs, particularly from young tissue, possess superior regenerative capacity and an excellent safety profile.
  • Applications for liver cirrhosis are anticipated globally.

How Does Stem Cell Therapy Work in Liver Cirrhosis?

Stem Cell Therapy addresses liver cirrhosis from three directions: repairing damaged liver cells, inhibiting fibrosis, and reducing chronic inflammation, promoting liver regeneration.

When stem cells are injected into the body, how can a hardened liver be regenerated? The key is that stem cells "replenish lost cells", "release repair factors", and "inhibit immune escape" inpendekatan terpadu tiga arah.

Damaged Liver Cells Regenerate (Replacement Effect)

A subset of stem cells differentiates into hepatocytes, thereby directly compensating for the lost liver function.

When MSCs reach the liver, a small fraction of them differentiate into liver-like cells, directly replacing some of the damaged liver tissue.
With this, the recovery of liver functions such as detoxification and protein synthesis can be expected.

Secretion of repair factors for liver healing (Paracrine effect)

Stem cells abundantly secrete pro-regenerative factors, thereby supporting overall liver recovery.

MSC release cytokines with anti-inflammatory action and growth factors that promote tissue repair.
Hereby,

  • Attenuation of chronic inflammation
  • Inhibition of fibrosis progression
  • Restorative macrophage activation promoting tissue regeneration

Such an effect is achieved, and the liver environment is rendered more amenable to regeneration.

Modulating Immunity to Attenuate Inflammation (Immunomodulatory Effect)

Suppressing excessive immune responses, preventing further damage to the liver.

MSC suppresses the overactivity of T and B cells, thereby mitigating chronic inflammation. This, in turn, disrupts the cycle of hepatic damage and contributes to preventing the exacerbation of complications.

In this way, Stem Cell Therapy addresses liver cirrhosis with a three-pronged integrated approach:completing new liver cells, repairing liver damage, and soothing inflammationThis regenerative ability, which cannot be achieved with other treatments, can be said to be the greatest feature of Stem Cell Therapy.

Key Points

  • Some MSCs differentiate into liver-like cells, supplementing lost function.
  • Releasing repair factors to prepare the liver regeneration environment.
  • Inhibits the progression of fibrosis and preserves liver elasticity.
  • Alleviating chronic inflammation through immune modulation, preventing further damage.
  • A tripartite integrated approach enables a comprehensive approach to liver cirrhosis.

How Effective is Stem Cell Therapy? Clinical Evidence Demonstrates Its Effectiveness.

Clinical research worldwide is beginning to show that Stem Cell Therapy for liver cirrhosis results in improved liver function, symptom relief, reduced fibrosis, and even increased survival rates.

"Does Stem Cell Therapy really work?" -- This is the most important point for patients and families. Recently,bukti ilmiahReports supporting the effectiveness of Stem Cell Therapy for liver cirrhosis continue to be published from various parts of the world.

Increased Liver Function Test Data

In several meta-analyses and clinical trials, significantly elevated blood parameters (e.g., ALT, AST, bilirubin, albumin) have been reported in patients undergoing Stem Cell Therapy. This enhancement leads to improved fundamental liver functions, including detoxification, metabolism, and nutrient storage, while also alleviating symptoms such as jaundice and edema.

Worsening of Distressing Symptoms and Quality of Life

From the patient's perspective, there have been continuous reports of reduced fatigue, restoration of appetite, and improvement in abdominal distension due to ascites, leading to an enhanced quality of life (QOL).

Beyond mere numerical improvements, profound changes in daily life, such as restored mobility and the ability to enjoy meals, have been realized.

Fibrosis Repair and Liver Regeneration

Following Stem Cell Therapy, cases of increased liver volume on CT or MRI scans and reduction in liver fibrosis have been reported. While complete normalization has not been observed, there is an indication that tissue regeneration may be commencing.

Improved Survival Rate

Analysis of long-term monitoring data revealed that patients with severe hepatic cirrhosis undergoing Stem Cell Therapy demonstrated a significantly higher survival rate compared to the control group. This outcome represents not only life extension, but an "extension of healthy lifespan" with an anticipated improvement in quality of life.

Key Points

  • ALT, AST, albumin, and other liver function indicators are elevated.
  • Fatigue, ascites, and other symptoms are reduced, leading to an improved quality of life (QOL).
  • Reduced fibrosis and hepatic tissue regeneration have been reported.
  • Improved survival rates are also recommended in patients with severe liver cirrhosis.
  • Developing into a promising new treatment option for liver cirrhosis.

Is Stem Cell Therapy Safe? Concerns Regarding Adverse Effects?

In previous clinical studies, it has been confirmed that Stem Cell Therapy (especially MSCs derived from Wharton's Jelly) has few serious side effects and high safety.

The paramount concern when introducing a novel therapy is safety. While regenerative therapy remains an evolving field, prior clinical research on Stem Cell Therapy has clearly demonstrated a very low incidence of serious adverse events.

Assessing Safety from Prior Clinical Research Data

According to a recent meta-analysis, in the treatment of liver cirrhosis using MSCs derived from bone marrow or umbilical cord, there was no difference in the incidence rate of adverse events between the treatment group and the control group, and no serious adverse effects were confirmed.

Specifically, MSC derived from the umbilical cord have low immunogenicity, which is a featureThat immune rejection reactions are almost non-existent, even when provided by others., and excellent in terms of safety.

Reported Possible Side Effects

The vast majority of reported side effects have been extremely mild and transient, posing no serious risk.

  • Transient fever
  • Mild headache
  • Mild pain or discomfort at the injection site

It typically resolves spontaneously, and additional treatment is rarely required.

On Cancer Risk

"If I receive stem cells, will I get a tumor?" Such concerns also exist, butpenelitian sebelumnya tidak menunjukkan insidensi hepatoma hati baru akibat injeksi MSCConversely, it has been suggested that the risk of liver cancer is reduced in the group receiving Stem Cell Therapy.

Currently, Stem Cell Therapy (especially treatments utilizing Wharton's Jelly-derived Mesenchymal Stem Cells (MSCs)) is regarded as a treatment option with an excellent safety profile for patients with liver cirrhosis. While long-term observation is still required, compared to traditional liver transplantation, it holds significant promise as a regenerative therapy with reduced risks.

Key Points

  • Hardly any serious side effects have been reported.
  • Mild and temporary side effects (fever, headache, etc.) are rare.
  • Immunological rejection is very rare (particularly with umbilical cord-derived MSCs).
  • The cancer risk is also refuted by current research.
  • Compared to liver transplantation, this is a treatment option with a reduced patient burden.

Hope for the Future: Transformation Through Regenerative Therapy

Stem cell therapy for hepatic cirrhosis represents a cutting-edge regenerative approach currently undergoing accelerated research worldwide. For hepatic cirrhosis, previously considered an "incurable disease," efforts utilizing autologous or allogeneic stem cells to regenerate the liver have begun to yield promising results.

Specifically, umbilical cord-derived mesenchymal stem cells (WJ-MSCs) are anticipated to be a potent therapeutic tool for the future treatment of liver cirrhosis, owing to their youthful characteristics, high regenerative capacity, and favorable safety profile. For patients and families afflicted by liver cirrhosis, Stem Cell Therapy is emerging as a new beacon of hope.

The courage to take a single step could transform the future. The day when the traditional understanding of liver cirrhosis is redefined through regenerative therapy is not far off.

Referensi